Anzeige
Mehr »
Login
Montag, 27.01.2025 Börsentäglich über 12.000 News von 683 internationalen Medien
US-Präsident setzt auf die Solana Blockchain! Diese Krypto-Perle profitiert enorm!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A14UTJ | ISIN: IE00BWY4ZF18 | Ticker-Symbol: C5H
Frankfurt
24.01.25
08:18 Uhr
2,130 Euro
+0,015
+0,71 %
Branche
Bau/Infrastruktur
Aktienmarkt
ISEQ-20
1-Jahres-Chart
CAIRN HOMES PLC Chart 1 Jahr
5-Tage-Chart
CAIRN HOMES PLC 5-Tage-Chart
RealtimeGeldBriefZeit
2,1002,14026.01.
Dow Jones News
197 Leser
Artikel bewerten:
(1)

Cairn Homes Plc: Holding(s) in Company

Finanznachrichten News

DJ Cairn Homes Plc: Holding(s) in Company

Cairn Homes Plc (CRN) 
Cairn Homes Plc: Holding(s) in Company 
22-Jan-2025 / 09:59 GMT/BST 
=---------------------------------------------------------------------------------------------------------------------- 
Standard Form TR-1 
Standard form for notification of major holdings 
NOTIFICATION OF MAJOR HOLDINGS (to be sent to the relevant issuer and to the Central Bank of Ireland)i 
 
1. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attachedii: 
Cairn Homes PLC (SEDOL: BWY4ZF1) 
 
2. Reason for the notification (please tick the appropriate box or boxes): 
[X] An acquisition or disposal of voting rights 
[ ] An acquisition or disposal of financial instruments 
[ ] An event changing the breakdown of voting rights 
[ ] Other (please specify)iii: 
 
3. Details of person subject to the notification obligationiv: 
Name: 1Lansdowne Partners International Limited;            City and country of registered office (if 
                                    applicable): 
2Lansdowne Partners Limited; 
                                    65 Curzon Street, London W1J 8PE 
3Lansdowne Partners (UK) LLP; 
 
 
 
4. Full name of shareholder(s) (if different from 3.)v: Nortrust Nominees Ltd, CGML PB CLIENT LANSDOWNE DM LO KY M, 
Morgan Stanley Client Securities Nominees Limited and The Bank of New York Nominees Limited. 
5. Date on which the threshold was crossed or reachedvi:  20/01/2025 
6. Date on which issuer notified:  21/01/2025 
7. Threshold(s) that is/are crossed or reached:  3% 
8. Total positions of person(s) subject to the notification obligation: 
                              % of voting rights 
                  % of voting rights    through financial    Total of both Total number of 
                  attached to shares    instruments       in % (9.A +  voting rights of 
                  (total of 9.A)      (total of 9.B.1 +    9.B)      issuervii 
                              9.B.2) 
Resulting situation on the date on 
which threshold was crossed or 
reached              2.85%                      2.85%     620,247,107 
Position of previous notification 3.56%                      3.56% 
(if applicable) 
 
9. Notified details of the resulting situation on the date on which the threshold was crossed or reachedviii: 
A: Voting rights attached to shares 
            Number of voting rightsix    % of voting rights 
Class/type of 
shares 
ISIN code (if     Direct       Indirect   Direct            Indirect 
possible) 
 
IE00BWY4ZF18               17,734,560                 2.85% 
 
 
SUBTOTAL A                17,734,560                 2.85% 
 
B 1: Financial Instruments according to Regulation 17(1)(a) of the Regulations 
Type of financial    Expiration Exercise/      Number of voting rights that may be acquired % of voting rights 
instrument        datex   Conversion Periodxi if the instrument is exercised/converted. 
 
 
 
                  SUBTOTAL B.1 
 
B 2: Financial Instruments with similar economic effect according to Regulation 17(1)(b) of the Regulations 
Type of financial   Expiration  Exercise/  Physical or cash                     % of voting 
instrument       datex    Conversion settlementxii     Number of voting rights      rights 
                  Period xi 
 
 
 
                        SUBTOTAL B.2 
 
10. Information in relation to the person subject to the notification obligation (please tick the applicable box): 
 
[ ] Person subject to the notification obligation is not controlled by any natural person or legal entity and does not 
control any other undertaking(s) holding directly or indirectly an interest in the (underlying) issuer.xiii 
 
[X] Full chain of controlled undertakings through which the voting rights and/or the 
financial instruments are effectively held starting with the ultimate controlling natural person or legal entityxiv: 
 
Lansdowne Partners International Limited is the parent undertaking of Lansdowne Partners Limited which is the 
First Corporate Member of Lansdowne Partners (UK) LLP. 
         % of voting rights if it    % of voting rights through financial    Total of both if it equals 
Namexv      equals or is higher than the  instruments if it equals or is higher than or is higher than the 
         notifiable threshold      the notifiable threshold          notifiable threshold 
Lansdowne 
Partners     2.85%                                   2.85% 
International 
Limited 
Lansdowne 
Partners Limited 
Lansdowne 
Partners (UK)  2.85%                                   2.85% 
LLP 
 
11. In case of proxy voting: [name of the proxy holder] will cease to hold [% and number] voting rights as of [date] N/ 
A 
 
 
12. Additional informationxvi: 
 

Done at London on 21/01/2025

----------------------------------------------------------------------------------------------------------------------- Dissemination of a Regulatory Announcement, transmitted by EQS Group. The issuer is solely responsible for the content of this announcement.

-----------------------------------------------------------------------------------------------------------------------

ISIN:      IE00BWY4ZF18 
Category Code: HOL 
TIDM:      CRN 
LEI Code:    635400DPX6WP2KKDOA83 
OAM Categories: 2.3. Major shareholding notifications 
Sequence No.:  372177 
EQS News ID:  2072717 
 
End of Announcement EQS News Service 
=------------------------------------------------------------------------------------
 

Image link: https://eqs-cockpit.com/cgi-bin/fncls.ssp?fn=show_t_gif&application_id=2072717&application_name=news&site_id=dow_jones%7e%7e%7ef1066a31-ca00-4e1a-b0a4-374bd7d0face

(END) Dow Jones Newswires

January 22, 2025 05:00 ET (10:00 GMT)

© 2025 Dow Jones News
Gewinner im Megamarkt
Biotechnologie ist eine der bedeutendsten Zukunftstechnologien unserer Zeit. Zahlreiche Biotechnologie- und Pharmakonzerne haben sich unter anderem dem Kampf gegen Tumorerkrankungen verschrieben. Der weltweite Markt für Krebsmedikamente verzeichnet ein stetiges Wachstum. Für das Jahr 2025 wird ein Umsatz von etwa 190,3 Milliarden Euro prognostiziert, mit einer erwarteten jährlichen Wachstumsrate von 6,42% bis 2029, was zu einem geschätzten Marktvolumen von 244,1 Milliarden Euro führen würde.

Wir haben 3 aussichtsreiche Biotechnologieaktien mit Schwerpunkt Erforschung und Entwicklung von Wirkstoffen gegen Tumorerkrankungen ausfindig gemacht, die in den kommenden Monaten und Jahren erhebliches Aufwärtspotenzial versprechen und Vervielfachungspotenzial besitzen.

Fordern Sie jetzt unseren neuen kostenlosen Spezialreport an und erfahren Sie, welche 3 Biotech-Aktien durchstarten und zu Ihrem Börsenerfolg in 2025 beitragen könnten!
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.